- Filed
- Dec 14, 2021 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2022 · Dec 10, 2021 | 26.36M sh |
| Cash And Equivalents | Q3 2022 · Oct 30, 2021 | 13.37M |
| Cash And Equivalents | Q3 2022 · Jul 31, 2021 | 12.05M |
| Cash And Equivalents | Q3 2022 · Jan 30, 2021 | 30.2M |
| Cash And Equivalents | Q3 2022 · Oct 31, 2020 | 21.93M |
| Cash And Equivalents | Q3 2022 · Jul 31, 2020 | 34.29M |
| Cash And Equivalents | Q3 2022 · Feb 1, 2020 | 46.34M |
| Current Liabilities | Q3 2022 · Oct 30, 2021 | 20.3M |
| Current Liabilities | Q3 2022 · Jan 30, 2021 | 112.18M |
| Total Liabilities | Q3 2022 · Oct 30, 2021 | 23.02M |
| Total Liabilities | Q3 2022 · Jan 30, 2021 | 112.53M |
| Current Assets | Q3 2022 · Oct 30, 2021 | 62.61M |
| Current Assets | Q3 2022 · Jan 30, 2021 | 74.35M |
| Total Assets | Q3 2022 · Oct 30, 2021 | 69.76M |
| Total Assets | Q3 2022 · Jan 30, 2021 | 81.24M |
| Shares Diluted | Q3 2022 · Oct 31, 2020 | 26.77B sh |
| Shares Diluted restated | Q3 2022 · Oct 31, 2020 | 26.14B sh |
| Operating Cash Flow | Q3 2022 · Oct 31, 2020 | −12.02M |
| Operating Cash Flow | Q3 2022 · Oct 31, 2020 | −19.9M |
| Stockholders Equity | Q3 2022 · Oct 31, 2020 | −4.54M |
| Stockholders Equity | Q3 2022 · Feb 1, 2020 | 23.35M |
| Sga Expense | Q3 2022 · Oct 31, 2020 | 7.12M |
| Sga Expense | Q3 2022 · Oct 31, 2020 | 35.88M |
| Net Income | Q3 2022 · Oct 31, 2020 | 14.47M |
| Net Income | Q3 2022 · Oct 31, 2020 | −28.71M |
| Operating Income | Q3 2022 · Oct 31, 2020 | 14.45M |
| Operating Income | Q3 2022 · Oct 31, 2020 | −25.81M |
| Gross Profit | Q3 2022 · Oct 31, 2020 | 10.83M |
| Gross Profit | Q3 2022 · Oct 31, 2020 | 34.09M |
| Cost Of Revenue | Q3 2022 · Oct 31, 2020 | 15.4M |
| Cost Of Revenue | Q3 2022 · Oct 31, 2020 | 47.41M |